Lupin Limited (LUPIN) — Board Meeting | 6 January 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Lupin Limited's board unanimously approved the appointment of Mr. Anand Kripalu as an Additional Director (Non-Executive, Independent) effective February 01, 2026, for a five-year term through January 31, 2031, subject to shareholder approval. Kripalu brings 30+ years of FMCG industry experience, including roles as MD & CEO of Diageo India and Mondelez India, plus advanced degrees from IIM Calcutta and IIT Madras. He currently serves as Executive Director at EPL Limited and holds independent directorships at Swiggy and United Breweries.

📄 View Original Announcement (PDF)

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

📊 More LUPIN filings

See all LUPIN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LUPIN — Free

Free account · 2 AI queries/day